PMAM
CERE

Picton Mahoney Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Picton Mahoney Asset Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-250,000
Closed -$10.2M – 989
2024
Q2 		$10.2M Buy
250,000
+100,000
+67% +$4.09M 0.4% 83
2024
Q1 		$6.34M Sell
150,000
-75,000
-33% -$3.17M 0.19% 121
2023
Q4 		$9.54M Buy
+225,000
New +$9.54M 0.26% 79